Elevated CRP levels were strongly associated with lung cancer risk as a chronic inflammation marker and, subsequently, as a lung carcinogenesis biomarker (Chaturvedi et al., 2010; Gaur et al., 2019; Ji et al., 2022). The gene discussed is CRP; the disease is lung carcinoma.